Mebeverine alcohol finds its primary application in the field of pharmaceuticals, particularly as a metabolite of mebeverine, which is used to treat gastrointestinal disorders such as irritable bowel syndrome (IBS) and spastic conditions of the digestive tract. Its role is crucial in understanding the pharmacokinetics and pharmacodynamics of mebeverine, aiding in the development of more effective and targeted therapies. Additionally, it is studied for its potential therapeutic effects, as it contributes to the antispasmodic and smooth muscle relaxant properties observed in the parent drug. This metabolite is also significant in drug metabolism studies, helping researchers assess the safety, efficacy, and potential side effects of mebeverine in patients.